Why most GCC brands fail at commercial execution
In the Gulf Cooperation Council (GCC), consumer health and FMCG brands operate in one of the most dynamic and concentrated retail environments in the world. With populations growing, disposable incomes recovering and modern trade rapidly expanding, the opportunity is immense. Yet, despite aggressive marketing budgets and stunning product launches, a surprising number of brands fail to gain meaningful traction.
Why do so many brands stumble in a region primed for growth? The answer rarely lies in the product itself. More often than not, the failure is rooted in commercial execution.
I believe your brand is not what you say: it is what the market is willing to choose. When brands fail in the GCC, it is typically because they treat the region as a single monolith, mismanage their distributor relationships, or fail to bridge the gap between high-level strategy and shelf-level execution.
Here is a closer look at why most GCC brands fail at commercial execution, and how leaders can engineer market preference instead.
1. Treating the GCC as a single monolith
A brand owner walking into a meeting in Dubai with a “GCC strategy” has already made their first mistake. The GCC is not a single market; it is a collection of distinct countries with varying demographics, retail structures and consumer behaviours1.
Treating the region as a monolith leads to misaligned product positioning and wasted budgets. For example, a premium, health-forward functional beverage might find immediate success in the UAE, where the retail infrastructure is built for international brands and consumers are willing to pay a premium for quality and convenience1. However, applying that same volume-based strategy in Saudi Arabia, a market driven by a younger, rapidly urbanising population looking for everyday household staples, will likely result in failure1.
Successful commercial execution requires market-specific strategies. Brands must align their product positioning with the actual dynamics of the target country, whether that means prioritising the UAE for premium goods, Saudi Arabia for mass-market scale, or Kuwait and Qatar for functional health products1.
2. Over-reliance on distributor models
For many consumer health and FMCG companies entering the GCC, appointing a local distributor is the default route to market. However, over-reliance on distributors is a significant risk factor. The biggest risk in GCC FMCG isn’t cost; it is distributor dependency.
Many distributor models in the region are built for volume rather than profitability or brand building. When brands export their strategy without building regional trust or committing to long-term partnerships, they often find their products over-distributed without achieving outlet productivity. This leads to empty shelves during critical promotional periods, lost sales and, ultimately, a breakdown in the commercial experience.
Brands that succeed do not just hand over their products and hope for the best. They actively manage their route to market, treating distributors as strategic partners rather than mere logistics providers. This involves clear communication, shared KPIs and a deep understanding of supply chain dynamics from origin to shelf1.
3. The strategy-execution gap at the shelf
The most brilliant marketing campaign cannot save a product that is out of stock or poorly merchandised. In the GCC, the shift towards modern trade, such as hypermarkets and convenience stores, has intensified the battle for shelf space.
Winning brands understand that commercial experience turns interest into conversion. Every touchpoint must increase consumer confidence and reduce friction. Yet many brands fail to detect execution gaps in the field. They might have a solid route-to-market blueprint, but if the product is not available when the consumer is ready to buy, the strategy fails.
This strategy-execution gap often shows up as poor shelf placement, inconsistent pricing across channels, or a failure to capitalise on seasonal demand spikes such as Ramadan or Hajj1. To close this gap, companies must invest in retail execution discipline, making sure their products are not only available but also highly visible and competitively priced.
4. Failing to engineer market preference
Most companies invest in marketing as if attention were the ultimate goal. But in a crowded consumer health market, attention is not enough. Preference is. The critical question is this: when the moment of decision arrives, do they choose you?
Market preference is engineered through relevance, trust, strategic clarity and a seamless commercial experience. Brands that fail at execution often speak from the inside out, focusing on their features rather than the visible customer problem or market tension. They fail to build the trust needed to reduce perceived risk, and their confused strategies lose momentum before reaching the consumer.
The path to commercial excellence
To win in the GCC, consumer health brands must move beyond generic strategies and focus on disciplined commercial execution. This means:
- Micro-segmenting the market: understanding the distinct needs of consumers in the UAE, Saudi Arabia and the other GCC nations.
- Actively managing route to market: building strong, accountable relationships with distributors.
- Closing the execution gap: making sure retail execution holds up at shelf level.
- Engineering preference: aligning strategy, brand and experience so the market chooses you first.
Sources
- ASAFI, “You Have a FMCG Product? Which GCC Market Should You Enter before 2030.” asafi.com